No Data
xilong scientific (002584.SZ): intends to increase capital to its wholly-owned subsidiary.
On November 29, Glonghui announced that xilong scientific (002584.SZ) proposed to enhance the overall competitiveness of its wholly-owned subsidiaries, yunnan yinghe new energy materials co., ltd. (referred to as "yunnan yinghe"), guangzhou xilong chemical co., ltd. (referred to as "guangzhou xilong"), and shanghai xilong chemical co., ltd. (referred to as "shanghai xilong"). To promote the healthy operation and sustainable development of the company and its subsidiaries, it plans to increase capital through cash by 100 million yuan for yunnan yinghe, 79 million yuan for guangzhou xilong, and 30 million yuan for shanghai xilong. The capital increase will be completed.
Xilong Scientific's (SZSE:002584) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Xilong Science: Report for the third quarter of 2024
Xilong Scientific (002584.SZ) released its performance for the first three quarters, with a net income of 64.1861 million yuan, a year-on-year increase of 117.61%.
xilong scientific (002584.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
xilong scientific (002584.SZ): The net income in the first three quarters was 64.1861 million yuan, a year-on-year increase of 117.61%.
On October 29, Gelonhui announced the third quarter report of xilong scientific (002584.SZ) for 2024, with the company's revenue reaching 6.553 billion yuan in the first nine months, a year-on-year increase of 13.16%; the net income attributable to shareholders of the listed company was 64.1861 million yuan, a year-on-year increase of 117.61%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 62.7133 million yuan, a year-on-year increase of 175.37%; and the basic earnings per share was 0.11 yuan.
Xilong Scientific (002584.SZ): The actual controlling shareholder and concerted action parties intend to transfer 5.98% of the shares by agreement.
GeLongHui October 21st | Xilong Scientific (002584.SZ) announced that it has received notification from the company's actual controller and concerted action persons, Mr. Huang Shaoqun, Mr. Huang Weibo, Mr. Huang Zhenkai, and Mr. Huang Zhenjie: Mr. Huang Shaoqun, Mr. Huang Weibo, Mr. Huang Zhenkai, and Mr. Huang Zhenjie signed the 'Equity Transfer Agreement' with Shanghai Jingge Private Equity Fund Management Partnership Enterprise (Limited Partnership) on October 21, 2024 (representing the 'Jingge Win-Win Exclusive No. 11 Private Equity Securities Investment Fund'). Huang Shaoqun, Huang Weibo, Huang Zhenkai, and Huang Zhenjie transferred 3,500,0 of the company's shares through agreement transfer method.
Xilong Scientific Co., Ltd. (SZSE:002584) Surges 42% Yet Its Low P/S Is No Reason For Excitement
